People
Björn Kuhl
Björn Kuhl is Principal at M Ventures. Biotech principal who joined2021 after Merck strategy consulting, Sandoz portfolio/business development and IMS/IQVIA consulting. Holds McGill experimental-medicine PhD, London biomedical-sciences MSc and Lübeck molecular-biotechnology BSc; conducted RagonInstitute immunology/virology research.
Roles
M Ventures
CurrentPrincipal